John Hampton Arnold, Jr., M.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
High-Frequency Ventilation | 23 | 2015 | 88 | 4.270 |
Why?
|
Positive-Pressure Respiration | 22 | 2020 | 639 | 2.510 |
Why?
|
Respiration, Artificial | 32 | 2020 | 2630 | 2.480 |
Why?
|
Pulmonary Gas Exchange | 22 | 2012 | 379 | 2.280 |
Why?
|
Tomography | 12 | 2020 | 411 | 2.080 |
Why?
|
Intensive Care Units, Pediatric | 22 | 2021 | 1017 | 1.880 |
Why?
|
Lung Volume Measurements | 12 | 2012 | 375 | 1.550 |
Why?
|
Electric Impedance | 13 | 2020 | 757 | 1.440 |
Why?
|
Fluorocarbons | 11 | 2010 | 492 | 1.400 |
Why?
|
Acute Lung Injury | 5 | 2013 | 367 | 1.350 |
Why?
|
Respiratory Insufficiency | 13 | 2019 | 1230 | 1.290 |
Why?
|
Respiratory Distress Syndrome, Newborn | 8 | 2010 | 233 | 1.070 |
Why?
|
Respiratory Dead Space | 8 | 2019 | 31 | 1.070 |
Why?
|
Carbon Dioxide | 13 | 2012 | 1147 | 1.060 |
Why?
|
Lung | 19 | 2018 | 10002 | 0.840 |
Why?
|
Lung Injury | 6 | 2010 | 422 | 0.780 |
Why?
|
Ventilator Weaning | 8 | 2011 | 164 | 0.780 |
Why?
|
Breath Tests | 8 | 2015 | 299 | 0.690 |
Why?
|
Monitoring, Physiologic | 7 | 2017 | 1779 | 0.690 |
Why?
|
Prone Position | 5 | 2006 | 196 | 0.680 |
Why?
|
Tidal Volume | 10 | 2019 | 488 | 0.660 |
Why?
|
Pulmonary Ventilation | 5 | 2010 | 372 | 0.650 |
Why?
|
Extracorporeal Membrane Oxygenation | 10 | 2012 | 1462 | 0.640 |
Why?
|
Pulmonary Atelectasis | 3 | 2013 | 143 | 0.570 |
Why?
|
Nebulizers and Vaporizers | 2 | 2016 | 139 | 0.560 |
Why?
|
Ventilator-Induced Lung Injury | 3 | 2016 | 120 | 0.540 |
Why?
|
Respiratory Mechanics | 6 | 2011 | 699 | 0.500 |
Why?
|
Diaphragm | 3 | 2011 | 351 | 0.500 |
Why?
|
Lung Compliance | 5 | 2019 | 200 | 0.470 |
Why?
|
Oxygen | 8 | 2019 | 4227 | 0.470 |
Why?
|
Liquid Ventilation | 3 | 2003 | 7 | 0.460 |
Why?
|
Ribavirin | 1 | 2016 | 395 | 0.450 |
Why?
|
Infant | 36 | 2021 | 36193 | 0.450 |
Why?
|
Plethysmography | 2 | 2005 | 175 | 0.430 |
Why?
|
Child, Preschool | 38 | 2021 | 42232 | 0.420 |
Why?
|
Dexmedetomidine | 1 | 2017 | 319 | 0.420 |
Why?
|
Infant, Newborn | 33 | 2021 | 26202 | 0.420 |
Why?
|
Hernia, Diaphragmatic | 4 | 2010 | 245 | 0.420 |
Why?
|
Blood Gas Analysis | 5 | 2015 | 379 | 0.400 |
Why?
|
Respiratory Function Tests | 5 | 2012 | 1682 | 0.400 |
Why?
|
Child | 44 | 2021 | 80158 | 0.380 |
Why?
|
Goals | 1 | 2017 | 711 | 0.380 |
Why?
|
Pulmonary Alveoli | 4 | 2012 | 652 | 0.370 |
Why?
|
Barotrauma | 2 | 2016 | 39 | 0.370 |
Why?
|
Signal Processing, Computer-Assisted | 2 | 2017 | 1496 | 0.350 |
Why?
|
Hydrocarbons, Brominated | 6 | 2010 | 29 | 0.350 |
Why?
|
Hypnotics and Sedatives | 5 | 2017 | 1179 | 0.310 |
Why?
|
Sheep | 10 | 2004 | 1440 | 0.310 |
Why?
|
Intermittent Positive-Pressure Ventilation | 1 | 2008 | 15 | 0.310 |
Why?
|
Disease Models, Animal | 12 | 2013 | 18255 | 0.300 |
Why?
|
Persistent Fetal Circulation Syndrome | 2 | 2004 | 80 | 0.290 |
Why?
|
Anesthesia, Inhalation | 1 | 2008 | 220 | 0.280 |
Why?
|
Pharmacokinetics | 1 | 2007 | 86 | 0.280 |
Why?
|
Cardiac Output | 3 | 2003 | 831 | 0.280 |
Why?
|
Random Allocation | 5 | 2013 | 2395 | 0.270 |
Why?
|
Swine | 10 | 2013 | 5915 | 0.270 |
Why?
|
Critical Care | 7 | 2007 | 2697 | 0.270 |
Why?
|
Hemodynamics | 11 | 2015 | 4160 | 0.270 |
Why?
|
Anesthesia | 1 | 2017 | 1595 | 0.260 |
Why?
|
Intensive Care, Neonatal | 1 | 2008 | 199 | 0.260 |
Why?
|
Respiration | 2 | 2011 | 1656 | 0.260 |
Why?
|
Uteroglobin | 1 | 2005 | 56 | 0.250 |
Why?
|
Supine Position | 3 | 2006 | 205 | 0.250 |
Why?
|
Nitric Oxide | 5 | 2004 | 2136 | 0.250 |
Why?
|
Respiratory Tract Diseases | 1 | 2011 | 750 | 0.250 |
Why?
|
Plethysmography, Impedance | 1 | 2005 | 42 | 0.250 |
Why?
|
Isoflurane | 3 | 2012 | 384 | 0.250 |
Why?
|
Enteral Nutrition | 1 | 2011 | 794 | 0.240 |
Why?
|
Drug Delivery Systems | 1 | 2016 | 2226 | 0.230 |
Why?
|
Adolescent | 29 | 2021 | 88326 | 0.230 |
Why?
|
Ventilators, Mechanical | 5 | 2016 | 288 | 0.230 |
Why?
|
Prospective Studies | 22 | 2020 | 54423 | 0.220 |
Why?
|
Psychomotor Agitation | 1 | 2006 | 305 | 0.220 |
Why?
|
Antiviral Agents | 1 | 2016 | 3060 | 0.220 |
Why?
|
Humans | 90 | 2021 | 761596 | 0.210 |
Why?
|
Pulmonary Surfactants | 2 | 2004 | 162 | 0.210 |
Why?
|
Algorithms | 9 | 2016 | 14033 | 0.200 |
Why?
|
Intracranial Hemorrhages | 2 | 2004 | 822 | 0.190 |
Why?
|
Conscious Sedation | 1 | 2006 | 532 | 0.190 |
Why?
|
Animals | 35 | 2013 | 168475 | 0.190 |
Why?
|
Infant, Premature, Diseases | 2 | 2004 | 710 | 0.190 |
Why?
|
Neonatal Abstinence Syndrome | 2 | 1994 | 108 | 0.180 |
Why?
|
Quality Improvement | 1 | 2016 | 3802 | 0.180 |
Why?
|
Bronchiolitis | 1 | 2007 | 485 | 0.180 |
Why?
|
Pulmonary Circulation | 4 | 2003 | 737 | 0.180 |
Why?
|
Hypertension, Pulmonary | 4 | 2018 | 1578 | 0.180 |
Why?
|
Cephalexin | 1 | 2020 | 37 | 0.180 |
Why?
|
Predictive Value of Tests | 3 | 2015 | 15266 | 0.180 |
Why?
|
Hydrogen-Ion Concentration | 3 | 2015 | 2496 | 0.170 |
Why?
|
Pharmaceutical Preparations | 2 | 2007 | 1089 | 0.170 |
Why?
|
Sus scrofa | 2 | 2013 | 428 | 0.170 |
Why?
|
Hemoptysis | 1 | 2021 | 152 | 0.170 |
Why?
|
Lung Diseases | 3 | 2001 | 1909 | 0.160 |
Why?
|
Vital Signs | 1 | 2020 | 144 | 0.160 |
Why?
|
Male | 43 | 2021 | 360846 | 0.160 |
Why?
|
Retrospective Studies | 19 | 2021 | 80647 | 0.150 |
Why?
|
Total Lung Capacity | 1 | 1998 | 149 | 0.150 |
Why?
|
Fentanyl | 2 | 1991 | 434 | 0.150 |
Why?
|
Models, Biological | 4 | 2009 | 9469 | 0.150 |
Why?
|
Critical Illness | 4 | 2021 | 2723 | 0.150 |
Why?
|
Electrocardiography | 1 | 2011 | 6377 | 0.140 |
Why?
|
Administration, Inhalation | 3 | 2016 | 1157 | 0.140 |
Why?
|
Fluoroscopy | 1 | 2001 | 947 | 0.140 |
Why?
|
Pediatrics | 2 | 2007 | 3589 | 0.140 |
Why?
|
Arthritis, Infectious | 1 | 2020 | 347 | 0.130 |
Why?
|
Female | 38 | 2021 | 392705 | 0.130 |
Why?
|
Image Processing, Computer-Assisted | 2 | 2010 | 9001 | 0.130 |
Why?
|
Hyaline Membrane Disease | 2 | 1996 | 19 | 0.130 |
Why?
|
Osteomyelitis | 1 | 2020 | 407 | 0.130 |
Why?
|
Pneumonia | 1 | 2008 | 2143 | 0.130 |
Why?
|
Acute Disease | 6 | 2007 | 7237 | 0.120 |
Why?
|
Vasodilator Agents | 1 | 1999 | 973 | 0.120 |
Why?
|
Probability | 5 | 2019 | 2477 | 0.120 |
Why?
|
Polymorphism, Genetic | 1 | 2005 | 4243 | 0.120 |
Why?
|
Drug Monitoring | 1 | 2001 | 962 | 0.120 |
Why?
|
Computer Systems | 1 | 2016 | 470 | 0.120 |
Why?
|
Immunocompromised Host | 2 | 2015 | 858 | 0.120 |
Why?
|
Continuous Positive Airway Pressure | 1 | 2019 | 575 | 0.120 |
Why?
|
Intubation, Intratracheal | 4 | 2020 | 1333 | 0.120 |
Why?
|
Meconium Aspiration Syndrome | 2 | 2003 | 30 | 0.110 |
Why?
|
Aerosols | 1 | 2016 | 635 | 0.110 |
Why?
|
Functional Residual Capacity | 1 | 2012 | 70 | 0.110 |
Why?
|
Neuropsychological Tests | 1 | 2006 | 7054 | 0.100 |
Why?
|
Vascular Resistance | 3 | 2003 | 930 | 0.100 |
Why?
|
Standard of Care | 1 | 2016 | 551 | 0.100 |
Why?
|
Chromatography, High Pressure Liquid | 1 | 2016 | 1541 | 0.100 |
Why?
|
Bronchial Spasm | 1 | 2012 | 71 | 0.100 |
Why?
|
Treatment Outcome | 14 | 2017 | 64685 | 0.090 |
Why?
|
Human Experimentation | 1 | 1992 | 123 | 0.090 |
Why?
|
Staphylococcal Infections | 1 | 2020 | 1407 | 0.090 |
Why?
|
Length of Stay | 4 | 2020 | 6426 | 0.090 |
Why?
|
Fuzzy Logic | 1 | 2010 | 57 | 0.090 |
Why?
|
Medical Audit | 1 | 2011 | 453 | 0.090 |
Why?
|
Models, Theoretical | 2 | 2016 | 3575 | 0.090 |
Why?
|
Cross-Over Studies | 2 | 2012 | 2079 | 0.090 |
Why?
|
Automation | 2 | 2010 | 586 | 0.080 |
Why?
|
Therapeutic Irrigation | 2 | 2001 | 292 | 0.080 |
Why?
|
Botulism | 1 | 2009 | 21 | 0.080 |
Why?
|
Tomography, X-Ray Computed | 1 | 2013 | 20568 | 0.080 |
Why?
|
Resuscitation | 1 | 1994 | 673 | 0.080 |
Why?
|
Tandem Mass Spectrometry | 1 | 2016 | 1188 | 0.080 |
Why?
|
Biomedical Technology | 1 | 1992 | 211 | 0.080 |
Why?
|
Specialization | 1 | 1994 | 778 | 0.080 |
Why?
|
Technology Assessment, Biomedical | 1 | 1992 | 307 | 0.080 |
Why?
|
Electrodes | 1 | 2011 | 614 | 0.080 |
Why?
|
Dose-Response Relationship, Drug | 4 | 2010 | 10766 | 0.080 |
Why?
|
Adenoviruses, Human | 1 | 2010 | 255 | 0.080 |
Why?
|
Spirometry | 1 | 2011 | 929 | 0.080 |
Why?
|
Survival Rate | 5 | 2021 | 12723 | 0.080 |
Why?
|
Fungemia | 1 | 2008 | 57 | 0.070 |
Why?
|
Biopsy, Needle | 1 | 2013 | 1626 | 0.070 |
Why?
|
Hirschsprung Disease | 1 | 2009 | 163 | 0.070 |
Why?
|
Catheters | 1 | 2011 | 427 | 0.070 |
Why?
|
Shock, Septic | 1 | 1994 | 768 | 0.070 |
Why?
|
Reference Values | 2 | 2013 | 4920 | 0.070 |
Why?
|
Equipment Failure Analysis | 1 | 2010 | 847 | 0.070 |
Why?
|
Confidence Intervals | 1 | 2013 | 2927 | 0.070 |
Why?
|
Anesthetics, Inhalation | 1 | 2012 | 574 | 0.070 |
Why?
|
Feasibility Studies | 2 | 2016 | 5247 | 0.070 |
Why?
|
Infant, Premature | 3 | 2004 | 2107 | 0.070 |
Why?
|
Suction | 1 | 2007 | 266 | 0.070 |
Why?
|
Analysis of Variance | 2 | 2013 | 6228 | 0.070 |
Why?
|
Patient Care | 1 | 1992 | 622 | 0.070 |
Why?
|
Nursing Assessment | 1 | 2006 | 106 | 0.060 |
Why?
|
Software | 2 | 2017 | 4434 | 0.060 |
Why?
|
Intubation | 1 | 2006 | 139 | 0.060 |
Why?
|
Electronic Health Records | 2 | 2020 | 4811 | 0.060 |
Why?
|
Fungi | 1 | 2008 | 338 | 0.060 |
Why?
|
Severity of Illness Index | 3 | 2021 | 15843 | 0.060 |
Why?
|
Infant, Newborn, Diseases | 1 | 1990 | 589 | 0.060 |
Why?
|
Chest Wall Oscillation | 1 | 2004 | 15 | 0.060 |
Why?
|
Work of Breathing | 1 | 2004 | 56 | 0.060 |
Why?
|
Oxygenators, Membrane | 1 | 2004 | 56 | 0.060 |
Why?
|
Water-Electrolyte Balance | 1 | 2005 | 325 | 0.060 |
Why?
|
Internet | 1 | 2017 | 3093 | 0.060 |
Why?
|
Time Factors | 6 | 2018 | 39969 | 0.060 |
Why?
|
Inflammation Mediators | 1 | 2013 | 1886 | 0.060 |
Why?
|
Patient Discharge | 2 | 2021 | 3443 | 0.050 |
Why?
|
Nystatin | 1 | 2002 | 22 | 0.050 |
Why?
|
Research Design | 2 | 2006 | 6180 | 0.050 |
Why?
|
Anti-Bacterial Agents | 2 | 2020 | 7406 | 0.050 |
Why?
|
Health Status | 1 | 2016 | 4077 | 0.050 |
Why?
|
Candidiasis, Oral | 1 | 2002 | 57 | 0.050 |
Why?
|
Anesthetics | 1 | 2008 | 523 | 0.050 |
Why?
|
Fluconazole | 1 | 2002 | 157 | 0.050 |
Why?
|
Models, Animal | 1 | 2008 | 2112 | 0.050 |
Why?
|
Antifungal Agents | 2 | 2008 | 753 | 0.050 |
Why?
|
Boston | 2 | 2012 | 9327 | 0.050 |
Why?
|
Posture | 1 | 2006 | 957 | 0.050 |
Why?
|
Socioeconomic Factors | 1 | 2015 | 7828 | 0.050 |
Why?
|
Logistic Models | 2 | 2010 | 13255 | 0.050 |
Why?
|
Pressure | 1 | 2004 | 1154 | 0.050 |
Why?
|
Chronic Disease | 2 | 2015 | 9319 | 0.050 |
Why?
|
Bacteremia | 1 | 2008 | 980 | 0.050 |
Why?
|
Shock | 1 | 2003 | 314 | 0.050 |
Why?
|
Antibodies, Neutralizing | 1 | 2010 | 1943 | 0.050 |
Why?
|
Clinical Protocols | 2 | 2005 | 1440 | 0.040 |
Why?
|
Drug Tolerance | 2 | 1993 | 367 | 0.040 |
Why?
|
Instillation, Drug | 1 | 1999 | 32 | 0.040 |
Why?
|
Multivariate Analysis | 3 | 2004 | 12059 | 0.040 |
Why?
|
Antifibrinolytic Agents | 1 | 2003 | 292 | 0.040 |
Why?
|
Reproducibility of Results | 4 | 2006 | 20100 | 0.040 |
Why?
|
Peroxidase | 1 | 2003 | 609 | 0.040 |
Why?
|
Lung Diseases, Obstructive | 1 | 2000 | 308 | 0.040 |
Why?
|
Methicillin Resistance | 1 | 2020 | 198 | 0.040 |
Why?
|
Immunohistochemistry | 1 | 2013 | 11076 | 0.040 |
Why?
|
Emulsions | 1 | 1999 | 152 | 0.040 |
Why?
|
Pilot Projects | 1 | 2012 | 8633 | 0.040 |
Why?
|
Heart Diseases | 1 | 2012 | 2781 | 0.040 |
Why?
|
Partial Pressure | 1 | 2019 | 245 | 0.040 |
Why?
|
Antibodies, Viral | 1 | 2010 | 3156 | 0.040 |
Why?
|
Calibration | 1 | 2001 | 818 | 0.040 |
Why?
|
Nitrogen Dioxide | 2 | 1999 | 522 | 0.040 |
Why?
|
Empirical Research | 1 | 2019 | 120 | 0.040 |
Why?
|
Heart Valve Prosthesis Implantation | 2 | 2000 | 1553 | 0.040 |
Why?
|
Sodium Chloride | 1 | 2001 | 587 | 0.040 |
Why?
|
Adult | 13 | 2009 | 221210 | 0.040 |
Why?
|
Ventilation-Perfusion Ratio | 1 | 1998 | 117 | 0.040 |
Why?
|
Epoprostenol | 1 | 2018 | 247 | 0.040 |
Why?
|
Intensive Care Units, Neonatal | 1 | 2004 | 846 | 0.040 |
Why?
|
Bacteria | 1 | 2008 | 2199 | 0.040 |
Why?
|
Hemoglobins | 1 | 2003 | 1526 | 0.030 |
Why?
|
Tissue Distribution | 1 | 2001 | 2264 | 0.030 |
Why?
|
Risk Factors | 6 | 2021 | 74213 | 0.030 |
Why?
|
United States | 2 | 2019 | 72340 | 0.030 |
Why?
|
Linear Models | 2 | 2012 | 5872 | 0.030 |
Why?
|
Infusions, Intravenous | 2 | 1991 | 2217 | 0.030 |
Why?
|
Psychometrics | 1 | 2006 | 3065 | 0.030 |
Why?
|
Administration, Oral | 2 | 2020 | 4021 | 0.030 |
Why?
|
Drug Administration Schedule | 2 | 2020 | 4853 | 0.030 |
Why?
|
Models, Structural | 1 | 1996 | 340 | 0.030 |
Why?
|
Drug Evaluation, Preclinical | 1 | 2001 | 1334 | 0.030 |
Why?
|
Patient Selection | 2 | 2000 | 4244 | 0.030 |
Why?
|
Lung Transplantation | 2 | 1994 | 1310 | 0.030 |
Why?
|
Regional Blood Flow | 1 | 1998 | 1496 | 0.030 |
Why?
|
Prognosis | 3 | 2010 | 29629 | 0.030 |
Why?
|
Life Support Care | 1 | 1996 | 226 | 0.030 |
Why?
|
Longitudinal Studies | 1 | 2010 | 14608 | 0.030 |
Why?
|
Calorimetry | 1 | 1993 | 129 | 0.030 |
Why?
|
Microbial Sensitivity Tests | 1 | 2020 | 1936 | 0.030 |
Why?
|
Rabbits | 1 | 2000 | 4772 | 0.030 |
Why?
|
Dogs | 1 | 1998 | 3839 | 0.030 |
Why?
|
Equipment Design | 1 | 2001 | 3511 | 0.030 |
Why?
|
Cardiography, Impedance | 1 | 2013 | 40 | 0.030 |
Why?
|
Vagotomy, Proximal Gastric | 1 | 1992 | 8 | 0.030 |
Why?
|
Animals, Newborn | 1 | 1998 | 2677 | 0.030 |
Why?
|
Mathematics | 1 | 1993 | 707 | 0.030 |
Why?
|
Aortic Valve | 2 | 2000 | 1955 | 0.020 |
Why?
|
Staphylococcus aureus | 1 | 2020 | 1457 | 0.020 |
Why?
|
Therapeutic Human Experimentation | 1 | 1992 | 43 | 0.020 |
Why?
|
Third-Party Consent | 1 | 1992 | 66 | 0.020 |
Why?
|
Parental Consent | 1 | 1992 | 63 | 0.020 |
Why?
|
Heart Valve Prosthesis | 1 | 2000 | 1462 | 0.020 |
Why?
|
Thoracoscopy | 1 | 1992 | 181 | 0.020 |
Why?
|
Proxy | 1 | 2012 | 151 | 0.020 |
Why?
|
Genotype | 1 | 2005 | 12990 | 0.020 |
Why?
|
Ethics | 1 | 1991 | 94 | 0.020 |
Why?
|
Euthanasia, Passive | 1 | 1991 | 64 | 0.020 |
Why?
|
Peptic Ulcer | 1 | 1992 | 217 | 0.020 |
Why?
|
Heart Rate | 1 | 2002 | 4195 | 0.020 |
Why?
|
Quality of Life | 1 | 2012 | 13367 | 0.020 |
Why?
|
Wilms Tumor | 1 | 1993 | 379 | 0.020 |
Why?
|
Megacolon | 1 | 2009 | 11 | 0.020 |
Why?
|
Midazolam | 1 | 1991 | 266 | 0.020 |
Why?
|
Research Subjects | 1 | 1992 | 249 | 0.020 |
Why?
|
Intestinal Pseudo-Obstruction | 1 | 2009 | 49 | 0.020 |
Why?
|
Mycobacterium Infections | 1 | 1970 | 122 | 0.020 |
Why?
|
Evaluation Studies as Topic | 1 | 1992 | 1625 | 0.020 |
Why?
|
Tuberculin Test | 1 | 1970 | 206 | 0.020 |
Why?
|
Antihypertensive Agents | 1 | 2018 | 2024 | 0.020 |
Why?
|
Risk Assessment | 4 | 2021 | 23996 | 0.020 |
Why?
|
Neutralization Tests | 1 | 2010 | 728 | 0.020 |
Why?
|
Mycobacterium | 1 | 1970 | 251 | 0.020 |
Why?
|
Antibody Specificity | 1 | 2010 | 1060 | 0.020 |
Why?
|
Obesity | 1 | 2010 | 12947 | 0.020 |
Why?
|
Survival Analysis | 1 | 2000 | 10090 | 0.020 |
Why?
|
Biopsy | 1 | 1999 | 6766 | 0.020 |
Why?
|
Aortic Valve Stenosis | 1 | 2000 | 2001 | 0.020 |
Why?
|
Randomized Controlled Trials as Topic | 1 | 2004 | 10212 | 0.020 |
Why?
|
Regression Analysis | 1 | 1997 | 6345 | 0.020 |
Why?
|
Age Factors | 1 | 2004 | 18399 | 0.020 |
Why?
|
Finite Element Analysis | 1 | 2009 | 438 | 0.020 |
Why?
|
Uncertainty | 1 | 1992 | 754 | 0.020 |
Why?
|
Blood Pressure | 1 | 2002 | 8481 | 0.020 |
Why?
|
Withholding Treatment | 1 | 1991 | 617 | 0.020 |
Why?
|
Immunoglobulins | 1 | 2009 | 852 | 0.020 |
Why?
|
Radiography, Abdominal | 1 | 2009 | 534 | 0.020 |
Why?
|
Analgesia | 1 | 1991 | 461 | 0.020 |
Why?
|
Intensive Care Units | 1 | 1999 | 3744 | 0.020 |
Why?
|
Gram-Positive Bacterial Infections | 1 | 2008 | 343 | 0.020 |
Why?
|
Models, Anatomic | 1 | 2009 | 683 | 0.020 |
Why?
|
Mycoses | 1 | 2008 | 386 | 0.010 |
Why?
|
Constipation | 1 | 2009 | 563 | 0.010 |
Why?
|
Research | 1 | 1992 | 1982 | 0.010 |
Why?
|
Risk | 2 | 1992 | 9610 | 0.010 |
Why?
|
Prosthesis Design | 2 | 2000 | 2115 | 0.010 |
Why?
|
Diagnostic Errors | 1 | 2009 | 1265 | 0.010 |
Why?
|
Motor Activity | 1 | 1991 | 2715 | 0.010 |
Why?
|
Hypersensitivity | 1 | 1970 | 1171 | 0.010 |
Why?
|
Laparoscopy | 1 | 1992 | 2036 | 0.010 |
Why?
|
Gastrointestinal Diseases | 1 | 2008 | 1200 | 0.010 |
Why?
|
Opioid-Related Disorders | 1 | 1994 | 2164 | 0.010 |
Why?
|
Terminal Care | 1 | 1991 | 1761 | 0.010 |
Why?
|
Multicenter Studies as Topic | 1 | 2003 | 1702 | 0.010 |
Why?
|
Diagnosis, Differential | 2 | 2009 | 12973 | 0.010 |
Why?
|
Tuberculosis | 1 | 1970 | 2017 | 0.010 |
Why?
|
Sensitivity and Specificity | 1 | 2012 | 14665 | 0.010 |
Why?
|
Bioprosthesis | 1 | 2000 | 591 | 0.010 |
Why?
|
Stress, Psychological | 1 | 1991 | 4481 | 0.010 |
Why?
|
Methemoglobin | 1 | 1994 | 25 | 0.010 |
Why?
|
Infusions, Intra-Arterial | 1 | 1994 | 221 | 0.010 |
Why?
|
Morbidity | 1 | 1998 | 1752 | 0.010 |
Why?
|
Body Mass Index | 1 | 2010 | 12953 | 0.010 |
Why?
|
Pleurisy | 1 | 1992 | 54 | 0.010 |
Why?
|
Acetylcholine | 1 | 1994 | 629 | 0.010 |
Why?
|
Cohort Studies | 1 | 1995 | 41495 | 0.010 |
Why?
|
Biocompatible Materials | 1 | 2000 | 1685 | 0.010 |
Why?
|
Transplantation, Homologous | 1 | 2000 | 4807 | 0.010 |
Why?
|
Double Effect Principle | 1 | 1991 | 14 | 0.010 |
Why?
|
Euthanasia, Active | 1 | 1991 | 16 | 0.010 |
Why?
|
Follow-Up Studies | 2 | 2003 | 39106 | 0.010 |
Why?
|
Cross-Sectional Studies | 1 | 2012 | 26129 | 0.010 |
Why?
|
Jurisprudence | 1 | 1991 | 109 | 0.010 |
Why?
|
Euthanasia | 1 | 1991 | 58 | 0.010 |
Why?
|
Gastric Juice | 1 | 1970 | 59 | 0.010 |
Why?
|
Case-Control Studies | 1 | 2008 | 22176 | 0.010 |
Why?
|
Sepsis | 1 | 2003 | 2585 | 0.010 |
Why?
|
Mediastinal Neoplasms | 1 | 1992 | 401 | 0.010 |
Why?
|
Pleural Effusion | 1 | 1992 | 341 | 0.000 |
Why?
|
Intention | 1 | 1991 | 347 | 0.000 |
Why?
|
Attitude to Death | 1 | 1991 | 400 | 0.000 |
Why?
|
Clinical Trials as Topic | 1 | 2003 | 8002 | 0.000 |
Why?
|
Video Recording | 1 | 1992 | 967 | 0.000 |
Why?
|
Public Policy | 1 | 1991 | 559 | 0.000 |
Why?
|
Medical History Taking | 1 | 1970 | 774 | 0.000 |
Why?
|
Tissue and Organ Procurement | 1 | 1994 | 962 | 0.000 |
Why?
|
Young Adult | 1 | 2012 | 59260 | 0.000 |
Why?
|
Tissue Donors | 1 | 1994 | 2332 | 0.000 |
Why?
|
Hospital Mortality | 1 | 1998 | 5293 | 0.000 |
Why?
|
Antigens | 1 | 1970 | 1443 | 0.000 |
Why?
|
Body Weight | 1 | 1994 | 4618 | 0.000 |
Why?
|
Radiography, Thoracic | 1 | 1970 | 1302 | 0.000 |
Why?
|
Motivation | 1 | 1991 | 2006 | 0.000 |
Why?
|
Aged | 3 | 2000 | 169310 | 0.000 |
Why?
|
Lymph Nodes | 1 | 1970 | 3465 | 0.000 |
Why?
|
Neoplasm Staging | 1 | 1992 | 11120 | 0.000 |
Why?
|
Health Personnel | 1 | 1991 | 3335 | 0.000 |
Why?
|
Decision Making | 1 | 1991 | 3929 | 0.000 |
Why?
|
Postoperative Complications | 1 | 1998 | 15633 | 0.000 |
Why?
|
Pain | 1 | 1991 | 5073 | 0.000 |
Why?
|
Aged, 80 and over | 1 | 1998 | 58984 | 0.000 |
Why?
|
Physicians | 1 | 1991 | 4591 | 0.000 |
Why?
|
Middle Aged | 2 | 2000 | 220921 | 0.000 |
Why?
|
Lung Neoplasms | 1 | 1992 | 13381 | 0.000 |
Why?
|